Sunscreen

0
Pipeline Programs
2
Companies
4
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

2 companies ranked by most advanced pipeline stage

Pierre Fabre
Pierre FabreFrance - Aignan
1 program
RV4369A cosmetic productN/A1 trial
Active Trials
NCT05837208Completed26Est. Apr 2022
J&
Johnson & JohnsonNEW BRUNSWICK, NJ
1 program
Sunscreen AN/A3 trials
Active Trials
NCT06734299Completed45Est. Feb 2025
NCT05972434Completed82Est. Jul 2023
NCT05565625Completed97Est. Mar 2022

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
Johnson & JohnsonSunscreen A
Johnson & JohnsonSunscreen A
Pierre FabreRV4369A cosmetic product
Johnson & JohnsonSunscreen A

Clinical Trials (4)

Total enrollment: 250 patients across 4 trials

A Study to Evaluate Usage of Mineral Sunscreens With Differentiated Whitening Attributes in Multi-Cultural Skin Tones

Start: Dec 2024Est. completion: Feb 202545 patients
N/ACompleted

A Study of Two Facial Sunscreens to Assess Its Effect in Improving Hydration, Skin Barrier Function, and Skin Tone Uniformity Under Controlled and Normal Conditions of Use on the Face by Adult Participants

Start: Apr 2023Est. completion: Jul 202382 patients
N/ACompleted
NCT05837208Pierre FabreRV4369A cosmetic product

Determination of Product Thickness Applied on Different Areas of the Face Using a Multispectral Imaging Method

Start: Apr 2022Est. completion: Apr 202226 patients
N/ACompleted

A Study to Evaluate the Whitening Effect of Mineral Sunscreens in Multi-Cultural Skin Tones

Start: Dec 2021Est. completion: Mar 202297 patients
N/ACompleted

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

2 companies competing in this space